The microscopic method for the determination of insoluble particulate matter is a compendial test used to count and size subvisible particles in injectable pharmaceutical products by membrane filtration followed by light microscopy. Recognized by USP General Chapter 788, the Chinese Pharmacopoeia (ChP 0903), the Japanese Pharmacopoeia (JP 6.07), and the European Pharmacopoeia (EP 2.9.7), it serves as the reference technique for formulations that cannot be measured reliably by light obscuration, such as emulsions, colloids, liposomes, and viscous or opaque solutions. This article explains the technical principle, applicable sample types, testing workflow, acceptance limits, and practical applications of the microscopic particle count method.
Technical Overview
The microscopic method (also called the microscopic particle count test or membrane microscopy method) is a pharmacopoeial procedure for quantifying insoluble particulate matter in parenteral products. Subvisible particles in injections—typically in the 10 μm to 25 μm range and above—can originate from packaging components, manufacturing equipment, environmental contamination, drug degradation, or incompatibilities between the formulation and container-closure system. Because such particles may pose safety risks when administered intravenously, regulatory authorities impose strict limits on their number and size.
The principle of the method is straightforward: a measured volume of the product is filtered through a gridded microporous membrane filter that quantitatively retains insoluble particles. The membrane is then dried, made transparent or examined directly, and the retained particles are counted and sized under a calibrated microscope using an eyepiece micrometer. The longest dimension of each particle defines its size, and results are reported as the number of particles equal to or larger than 10 μm and 25 μm per container or per milliliter.
- Direct physical observation of particles, allowing morphological characterization (fibers, flakes, specks, crystals)
- Applicable to products where light obscuration is unsuitable or produces biased results
- Low background interference because the liquid matrix is removed during filtration
- Results traceable to calibrated microscope optics and certified particle size standards
- Retained particles can be recovered for subsequent identification by Raman, FTIR, or SEM-EDS analysis
Because the microscopic method sizes particles by their longest projected dimension while light obscuration reports equivalent spherical diameters, the two techniques use different acceptance limits, and their results are not directly interchangeable.
Testing Samples
Small-Volume Parenteral Products
Ampoules, vials, and prefilled syringes with a labeled volume of 100 mL or less, including solutions, suspensions after dissolution, and reconstituted lyophilized products, are tested individually. The entire contents of each container are filtered, and particle counts are reported on a per-container basis.
Large-Volume Parenteral Products
Infusion solutions, irrigating solutions, and other products with a labeled volume greater than 100 mL are tested by filtering a representative, well-mixed portion. Results are calculated and reported as particles per milliliter.
Sterile Powders and Freeze-Dried Formulations
Powders for injection are reconstituted with particle-free water or the specified diluent to the labeled volume, mixed gently to avoid introducing air bubbles or shear-induced particles, and then filtered and counted in the same manner as solution products.
Complex and Non-Aqueous Formulations
Emulsions, liposomal dispersions, colloidal suspensions, protein formulations that foam or film, highly viscous solutions, and colored or turbid products are the primary candidates for the microscopic method, since these matrices interfere with the optical sensing zone used in light obscuration.
Ophthalmic and Device-Related Samples
Intraocular and large-volume ophthalmic solutions, as well as rinses or extracts from medical devices and container-closure components, can be evaluated using an appropriately validated adaptation of the membrane microscopy procedure.
Testing Items
The core deliverables of the microscopic determination are:
- Number of particles equal to or greater than 10 μm per container (small-volume products) or per milliliter (large-volume products)
- Number of particles equal to or greater than 25 μm per container or per milliliter
- Morphological classification of observed particles, such as fibers, plates, granules, or amorphous debris
- Optional extended thresholds (for example 2 μm, 5 μm, or 50 μm) for research, troubleshooting, or formulation development purposes
- Comparison of results against compendial acceptance criteria and batch specification
Testing Methods
Apparatus and Materials
The test requires a binocular microscope (typically operated at approximately 100× total magnification with higher magnification available for confirming borderline particles), a calibrated eyepiece micrometer verified against a certified stage micrometer, a vacuum or pressure filtration assembly with smooth-walled funnel, and gridded membrane filters with a typical pore size of 0.45 μm that have been verified to quantitatively retain particles in the size range of interest. All solvents, wash water, glassware, and membranes must be filtered or rinsed to remove extraneous particles before use.
Environmental and Blank Controls
Testing is performed in a controlled environment, ideally a laminar-flow hood of ISO Class 5 or better, to minimize adventitious contamination. A blank control is run in parallel: the same volume of particle-free water or diluent used for the sample is filtered through a fresh membrane and counted. The blank is considered acceptable when it shows negligible contamination, typically fewer than five particles of 10 μm or larger per membrane, and the test is valid only if blank levels remain well below the specification.
Sample Preparation and Filtration
- Externally clean the containers and allow them to equilibrate to room temperature; mix gently by inversion without shaking.
- Filter the contents of the test container (or the measured aliquot for large-volume products) through the gridded membrane, maintaining gentle vacuum to avoid particle generation.
- Rinse the container walls and the filter funnel with successive portions of particle-free water or diluent to ensure quantitative transfer of particles onto the membrane.
- Draw air through the membrane briefly, then dry it in a covered Petri dish at ambient conditions or under gentle vacuum.
Microscopic Examination and Counting
The dried membrane is placed on the microscope stage, and the entire effective filtration area is systematically scanned using the printed grid to ensure complete coverage. Each particle is sized with the calibrated eyepiece micrometer, taking its longest dimension as the particle size, and particles at or above the 10 μm and 25 μm thresholds are tallied. A minimum of three containers per batch is normally tested unless otherwise specified by the applicable monograph or validated protocol.
Calculation and Acceptance Criteria
For small-volume injections, the counted particles are reported directly per container; for large-volume products, the count is divided by the volume filtered to give particles per milliliter. The widely harmonized compendial limits for the microscopic method are:
- Large-volume injections: not more than 12 particles of 10 μm or larger per mL, and not more than 2 particles of 25 μm or larger per mL
- Small-volume injections: not more than 3000 particles of 10 μm or larger per container, and not more than 300 particles of 25 μm or larger per container
These limits are intentionally lower than the corresponding light obscuration limits because the microscopic technique measures the maximum dimension of each particle rather than an equivalent circular diameter, which generally yields smaller counts for the same population. Method suitability, blank controls, and container-to-container variability must be assessed as part of a validated test protocol.
Applications
Beyond routine batch release, the microscopic determination of insoluble particles supports multiple quality and development activities:
- Release testing of injectable products whose physical properties preclude accurate light obscuration measurement
- Stability studies monitoring particulate growth over time under long-term and accelerated storage conditions
- Root-cause investigations of visible or subvisible particulate contamination and out-of-specification results
- Container-closure compatibility studies and screening of extractables or leachables from elastomer closures, glass, and plastic components
- Formulation and process development, including evaluation of filtration, filling, and handling operations
- Particle identification workstreams in which membrane-captured particles are transferred to Raman microscopy, FTIR microscopy, or SEM-EDS for material attribution
- Support of regulatory submissions, pharmacopoeial compliance, and independent third-party verification testing
FAQ
When must the microscopic method be used instead of light obscuration?
The microscopic method is the method of choice when light obscuration cannot be applied accurately, such as for emulsions, colloids, liposomes, products with reduced clarity or color, and highly viscous solutions. It is also used to confirm or investigate light obscuration results whenever direct visual evidence of particle morphology is required.
Why are the microscopic limits different from the light obscuration limits?
The two techniques define particle size differently: microscopy measures the longest projected dimension of a particle, while light obscuration converts the shadow cast by a particle into an equivalent spherical diameter. To remain equally protective of patient safety, the compendial limits are set at lower numeric values for the microscopic method (12 per mL versus 25 per mL for 10 μm particles in large-volume injections, for example).
What membrane and magnification are used?
A gridded membrane filter, commonly 0.45 μm pore size and either white or dark depending on particle contrast, retains the particles. Examination is typically performed at approximately 100× total magnification with a calibrated eyepiece micrometer; higher magnifications are used to resolve borderline particle sizes.
How is particle size defined in this test?
The size of a particle is taken as its longest dimension as measured on the membrane under the microscope, which is why irregularly shaped particles such as fibers may be counted at a larger size than they would be by an equivalent-diameter optical method.
How is background contamination controlled?
All apparatus, solvents, and membranes are pre-filtered or rinsed with particle-free water, testing is conducted in a clean laminar-flow environment, and a blank filtration is performed alongside every test. Valid results require blank counts to remain negligible relative to the specification, and blank values are never routinely subtracted from sample counts.
Can the particles on the membrane be identified?
Yes. One key advantage of membrane microscopy is that retained particles remain available for direct observation and subsequent chemical or elemental identification using Raman microscopy, infrared microscopy, or scanning electron microscopy with energy-dispersive X-ray spectroscopy, which is invaluable during contamination investigations.